Jiang H, Joy D A, Furuya T, Su X-z
Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-8132, USA.
J Postgrad Med. 2006 Oct-Dec;52(4):271-6.
Chloroquine (CQ) is the most successful antimalarial drug ever discovered. Unfortunately, parasites resistant to the drug eventually emerged after its large scale use and are now widespread. Although great progress in our understanding of the mechanisms of CQ action and CQ resistance (CQR) has been achieved over the past two decades, including the identification of the molecules responsible for CQR (e.g., Plasmodium falciparum chloroquine resistant transporter, PfCRT) many questions remain unanswered. Here we highlight recent advances in our understanding of the genetics and molecular mechanisms of CQR, with particular emphasis on the role of genes such as pfcrt and pfmdr1 in the resistance to CQ and other drugs. New drug development and applications will undoubtedly benefit from a better understanding of CQR, eventually leading to more effective malaria control measures.
氯喹(CQ)是有史以来最成功的抗疟药物。不幸的是,在其大规模使用后,对该药物产生抗性的寄生虫最终出现,且目前已广泛传播。尽管在过去二十年里,我们对氯喹作用机制和氯喹抗性(CQR)的理解取得了巨大进展,包括鉴定出负责CQR的分子(例如恶性疟原虫氯喹抗性转运蛋白,PfCRT),但许多问题仍未得到解答。在此,我们着重介绍在理解CQR的遗传学和分子机制方面的最新进展,特别强调诸如pfcrt和pfmdr1等基因在对CQ及其他药物抗性中的作用。更好地理解CQR无疑将有助于新药研发与应用,最终带来更有效的疟疾控制措施。